Kumar Neil bought BBIO
November 16, 2025 · Form 4 insider transaction
Kumar Neil bought 11,554 shares of BridgeBio Pharma, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
11,554
Price
N/A
Total value
N/A
InsiderKumar Neil
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 16, 2025
Filing dateNovember 18, 2025
Shares owned after287,787
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.